256 related articles for article (PubMed ID: 20826584)
1. Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes.
Petit JM; Guiu B; Masson D; Duvillard L; Jooste V; Buffier P; Terriat B; Bouillet B; Brindisi MC; Loffroy R; Robin I; Hillon P; Cercueil JP; Verges B
J Clin Endocrinol Metab; 2010 Dec; 95(12):E430-6. PubMed ID: 20826584
[TBL] [Abstract][Full Text] [Related]
2. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.
Petit JM; Guiu B; Masson D; Duvillard L; Jooste V; Buffier P; Bouillet B; Brindisi MC; Robin I; Gambert P; Verges B; Cercueil JP; Hillon P
Liver Int; 2011 Oct; 31(9):1332-6. PubMed ID: 21745307
[TBL] [Abstract][Full Text] [Related]
3. The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
Xia MF; Lin HD; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Bian H; Li XY; Gao X
Diabetologia; 2019 Apr; 62(4):644-654. PubMed ID: 30673802
[TBL] [Abstract][Full Text] [Related]
4. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
[TBL] [Abstract][Full Text] [Related]
5. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
[TBL] [Abstract][Full Text] [Related]
6. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
[TBL] [Abstract][Full Text] [Related]
7. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.
Kotronen A; Johansson LE; Johansson LM; Roos C; Westerbacka J; Hamsten A; Bergholm R; Arkkila P; Arola J; Kiviluoto T; Fisher RM; Ehrenborg E; Orho-Melander M; Ridderstråle M; Groop L; Yki-Järvinen H
Diabetologia; 2009 Jun; 52(6):1056-60. PubMed ID: 19224197
[TBL] [Abstract][Full Text] [Related]
8. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease.
Bhatt SP; Nigam P; Misra A; Guleria R; Pandey RM; Pasha MA
Metab Syndr Relat Disord; 2013 Oct; 11(5):329-35. PubMed ID: 23734760
[TBL] [Abstract][Full Text] [Related]
11. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
12. Isoleucine-to-methionine substitution at residue 148 variant of PNPLA3 gene and metabolic outcomes in gestational diabetes.
Bo S; Gambino R; Menato G; Canil S; Ponzo V; Pinach S; Durazzo M; Ghigo E; Cassader M; Musso G
Am J Clin Nutr; 2015 Feb; 101(2):310-8. PubMed ID: 25646328
[TBL] [Abstract][Full Text] [Related]
13. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
Guichelaar MM; Gawrieh S; Olivier M; Viker K; Krishnan A; Sanderson S; Malinchoc M; Watt KD; Swain JM; Sarr M; Charlton MR
Obesity (Silver Spring); 2013 Sep; 21(9):1935-41. PubMed ID: 23418085
[TBL] [Abstract][Full Text] [Related]
14. Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study.
Posadas-Sánchez R; López-Uribe ÁR; Posadas-Romero C; Pérez-Hernández N; Rodríguez-Pérez JM; Ocampo-Arcos WA; Fragoso JM; Cardoso-Saldaña G; Vargas-Alarcón G
Immunobiology; 2017 Oct; 222(10):960-966. PubMed ID: 27615511
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
Kantartzis K; Peter A; Machicao F; Machann J; Wagner S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Diabetes; 2009 Nov; 58(11):2616-23. PubMed ID: 19651814
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans.
Sevastianova K; Kotronen A; Gastaldelli A; Perttilä J; Hakkarainen A; Lundbom J; Suojanen L; Orho-Melander M; Lundbom N; Ferrannini E; Rissanen A; Olkkonen VM; Yki-Järvinen H
Am J Clin Nutr; 2011 Jul; 94(1):104-11. PubMed ID: 21525193
[TBL] [Abstract][Full Text] [Related]
17. Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients.
Gavril OI; Arhire LI; Gavril RS; Zota MI; Gherasim A; Nita O; Drugescu A; Oprescu AC; Esanu IM; Mitu F; Graur M; Mihalache L
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833467
[No Abstract] [Full Text] [Related]
18. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study.
Trunečka P; Míková I; Dlouhá D; Hubáček JA; Honsová E; Kolesár L; Lánská V; Fraňková S; Šperl J; Jirsa M; Poledne R
Dig Liver Dis; 2018 May; 50(5):490-495. PubMed ID: 29396131
[TBL] [Abstract][Full Text] [Related]
19. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP
Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
[TBL] [Abstract][Full Text] [Related]
20. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.
Romeo S; Sentinelli F; Dash S; Yeo GS; Savage DB; Leonetti F; Capoccia D; Incani M; Maglio C; Iacovino M; O'Rahilly S; Baroni MG
Int J Obes (Lond); 2010 Jan; 34(1):190-4. PubMed ID: 19844213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
